Effect of the 4 year treatment with donepezil and choline alphoscerate on the brain of Alzheimer’s disease patients

Key Points

• Cognitive function improved significantly after 4 years of treatment with donepezil and choline alphoscerate in Alzheimer's patients.
• Key evidence indicates that subjects exhibited notable improvement in cognitive assessments measured over the treatment period.
• Observational analysis across Alzheimer’s disease patients highlights the potential effect of combined therapy on brain function.
• Further investigation is essential to establish long-term efficacy and safety for Alzheimer's treatments.